Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditionsNovo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to ...
16 Sep, 2025, 05.30 PM IST
Study reveals a simple technique to ease knee arthritis pain, and it can be as effective as medication: What is gait retraining?A new study in The Lancet Rheumatology suggests gait retraining — making subtle changes to walking patterns — can ease knee osteoarthritis ...
29 Aug, 2025, 08.51 PM IST
Arthritis pain relief without drugs or surgery, study suggestsArthritis, a disorder affecting nearly one in four adults over 40, remains a resulting source of constant pain and disability. Osteoarthrit...
26 Aug, 2025, 09.49 PM IST
IIT Guwahati researchers develop tailored solutions based on regenerative therapies for knee meniscus tearsResearchers from the Indian Institute of Technology (IIT) Guwahati, in collaboration with the University of Animal and Fishery Sciences, Ko...
28 Mar, 2024, 08.23 PM IST
What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
02 Jan, 2024, 05.13 PM IST
Painkiller Meftal could cause adverse reactions: IPCThe commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (P...
09 Dec, 2023, 02.23 PM IST
Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet studyA recent study published in The Lancet Rheumatology journal predicts that nearly one billion people worldwide will be living with osteoarth...
24 Aug, 2023, 05.41 PM IST
One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
22 Aug, 2023, 02.14 PM IST
Scientists develop model for better diagnosis, treatment of osteoarthritisThe paper builds on another recent study the RIT-Cornell team published in Soft Matter that looked at how cartilage's properties resisted f...
19 Feb, 2022, 10.18 PM IST
Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsulesThe company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...
13 Jan, 2021, 02.03 PM IST
Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.
12 Oct, 2018, 10.26 AM IST
Unichem Labs gets USFDA nod for arthritis drugPiroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheum...
17 Apr, 2017, 01.03 PM IST
Stempeutics plans stem cell device launch in India by mid 2016The company is looking for a strategic partner to globalise and market this device in India and outside.
15 Oct, 2015, 02.36 PM IST
Cipla's Stempeutics gets process patent for Stempeucel from JapanStempeutics has received process patent from the Japan for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia.
08 Jun, 2015, 03.28 PM IST
Lupin launches generic version of Celebrex in US marketLupin had earlier signed a licensing agreement with Pfizer Inc for Celebrex, which has an annual sales of $ 2.54 billion in US market, it a...
11 Dec, 2014, 02.25 PM IST
Cadila gets USFDA nod to market arthritis drug EtodolacCadila Healthcare today said it has received US health regulator's nod to market Etodolac extended release tablets, used in the treatment o...
30 Jan, 2014, 05.07 PM IST
- Lupin gets USFDA approval for arthritis tablets
Lupin Pharmaceuticals Inc has been granted final approval by US Food and Drug Administration for Nabumetone tablets in strengths of 500mg a...
14 Jan, 2011, 02.58 PM IST